Growth potential Phreesia serves 180 million patient visits annually with a focus on patient activation and registration, scheduling, payments and clinical support. This indicates a large, scalable installed base in hospitals and health systems, suggesting opportunities to upsell or cross-sell additional modules, such as expanded payment partnerships, predictive scheduling, or enhanced patient outreach capabilities.
HealthTech recognition Being named to TIME's World’s Top HealthTech Companies list in 2026 reinforces Phreesia’s market credibility and innovation leadership. This can be leveraged in targeted outreach to enterprise buyers and procurement teams seeking proven, award-winning technology partners for patient intake and activation.
Strategic partnerships Recent product integrations with DeepIntent and the expansion of ProviderConnect Audiences suggest a strong emphasis on data-rich patient engagement and targeted outreach. This aligns well with selling data-driven marketing and engagement solutions, language for breadth in patient communications, and potential collaboration with digital marketing or adtech partners.
Financial health signals Phreesia operates with mid-market revenue scale and has raised substantial funding, indicating financial stability to support growth initiatives. For sales conversations, emphasize long-term value, ROI from streamlined registrations and payments, and potential pricing models aligned with health system budgets and capital cycles.
Leadership and talent Recognition of leaders such as Michael Rasbury on Becker’s Rising Stars list signals a strong executive and product leadership bench. This can reassure prospective buyers about strategic vision, product roadmap, and customer success focus, while enabling executive-to-executive conversations around partnership roadmaps and co-innovation opportunities.